People · Operator

Suran Olyha

Named in public records as an officer, director or promoter · active 2018–2020 · Healthtech

1
Companies
2
Filings
$20.4M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Envera Health, Inc.HealthtechSeries A$20.4M$8.5M2018
Operator network

Suran Olyha at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Brian Carney · 10 companies · 1 sharedBrian CarneyJ. Robert Mooney · 8 companies · 1 sharedJ. Robert MooneyDaniel Neuwirth · 7 companies · 1 sharedDaniel NeuwirthRobert Mooney · 4 companies · 1 sharedRobert MooneySpence McClelland · 4 companies · 1 sharedSpence McClellandDavid Cerino · 2 companies · 1 sharedDavid CerinoJim Riley · 2 companies · 1 sharedJim RileySusan Olyha · 2 companies · 1 sharedSusan OlyhaCheryl Michael · 1 companies · 1 sharedCheryl MichaelDaniel B. Neuwirth · 1 companies · 1 sharedDaniel B. NeuwirthErinne Dyer · 1 companies · 1 sharedErinne DyerJim Robert Riley · 1 companies · 1 sharedJim Robert RileyJohanna Epstein · 1 companies · 1 sharedJohanna EpsteinNancy Van Maren · 1 companies · 1 sharedNancy Van MarenTammy Mullins · 1 companies · 1 sharedTammy MullinsEnvera Health, Inc. · $20.4M raisedEnvera Health, Inc.Suran OlyhaSO
Suran Olyha Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Suran Olyha on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Brian Carney110
J. Robert Mooney18
Daniel Neuwirth17
Spence McClelland14
Robert Mooney14
Susan Olyha12
Jim Riley12
David Cerino12
Daniel B. Neuwirth11
Nancy Van Maren11
Erinne Dyer11
Johanna Epstein11
Tammy Mullins11
Jim Robert Riley11
Cheryl Michael11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.